Iodine uptake and the effect of radioiodine treatment after the addition of iodine to salt;Jodoptagelse og effekt af radiojodbehandling - Status efter jodtilsætning til husholdningssaltet

Ugeskrift for Laeger

Volumn 167, Issue 39, 2005, Pages 3684-3687

  Vej Hansen, Anders ^a,b   Nygaard, Birte ^a  

^a Endokrinologisk Afdeling J106 ^*  (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; DRUG EFFICACY; FEMALE; GOITER; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SYMPTOMATOLOGY; THYROIDITIS; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 26044480704     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lamberg BA. Endemic goitre in Finland and changes during 30 years of iodine prophylaxis. Endocrinological Exp 1986;20:35-47.
2. Levnedsmiddelstyrelsen. Jod - er der behov for berigelse af kosten? København: Levnedsmiddelstyrelsen, 1995.
3. Lind P, Kumnig G, Heinisch M et al. Iodine supplementation in Austria: methods and results. Thyroid 2002;10:903-7.
4. Nygaard B, Hegedüs L, Gervil M et al. Radioiodine treatment of multinodular non-toxic goitre. BMJ 1993;307:828-32.
5. Robertson JS, Nolan NG, Wahner HW et al. Thyroid radioiodine uptakes and scans in euthyroid patients. Mayo Clinic Proceedings 1975;50:79-84.
6. Schlumberger M, Fragu P, Hill C et al. Short and long term effects of radioiodine treatment on the iodine content of the thyroid gland. J Clin Endocrinol Metab 1984;59:893-8.
7. Koutras DA, Karaiskos KS, Piperingos GD et al. Treatment of endemic goitre with iodine and thyroid hormone alone or in combination (preliminary report). Endocrinological Exp 1986;20:57-65.
8. Pedersen-Bjergaard U, Kirkegaard C. Serum TSH and the response to radioiodine treatment of toxic multinodular goitre. Eur J Endocrinol 1997;137:365-9.
9. Ross ITH. Changes in radioiodine in New Zealand. NZ Med J 1975;82:380-1.
10. Heath RC, Gossain VV, Rovner DR. Alteration of radioactive iodine uptake after treatment of hyperthyroidism with iodine 131. South Med J 1988;81:601-5.
11. Nieuwlaat WA, Huysmans DA, van den Bosch HC et al. Pretreatment with a single, low dose of recombinant human thyreotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 2003;88:3121-9.
12. Silva MNC, Ileana GSR, Rossana R et al. Administration of a single dose of recombinant human thyreotropin enhances the efficacy of radioiodine treatment of large compressice multinodular goitres. Clin Endocrinol 2004;60:300-8.
13. Nygaard B, Faber J, Hegedüs L et al. 131-I treatment of nodular non-toxic goitre (review). Eur J Endocrinol 1996;134:15-20.
14. Bonnema SJ. Management of the multinodular goitre: current strategies and new approaches. Ph.D. Århus: eget forlag, 2002.
15. Wesche MFT, Tiel-v.Buul MMC, Lips P et al. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol 2001;86:998-1005.
16. Huysmans D, Hermus A, Edelbroek M et al. Radioiodine for nontoxic multinodular goiter. Thyroid 1997;7:235-9.
17. Knudsen N. Regional variations in goitre prevalence in Denmark - and the impact of tobacco smoking. Ph.D. København: eget forlag, 2001.
18. Huysmans DA, Hermus RMM, Cortens FHM et al. Large, compressive goiters treated with radioiodine. Ann Intern Med 1994;121:757-62.
19. Moli RL, Wesche MFT, Tiel-v.Buul et al. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre. Clin Endocrinol 1999;50:783-9.
20. Jarløv A, Hegedüs L, Kristensen LØ et al. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while. Clin Endocrinol 1995;43:325-9.